Amylyx Pharmaceuticals Inc. (NASDAQ: AMLX) stock jumped 1.22% on Tuesday to $27.40 against a previous-day closing price of $27.07. With 0.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.97 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $27.98 whereas the lowest price it dropped to was $26.70. The 52-week range on AMLX shows that it touched its highest point at $41.93 and its lowest point at $7.64 during that stretch. It currently has a 1-year price target of $50.00.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AMLX was up-trending over the past week, with a rise of 0.81%, but this was down by -9.54% over a month. Three-month performance dropped to -24.23% while six-month performance fell -21.69%. The stock gained 214.94% in the past year, while it has lost -25.85% so far this year. A look at the trailing 12-month EPS for AMLX yields -2.48 with Next year EPS estimates of 3.45. For the next quarter, that number is 0.11. This implies an EPS growth rate of -117.80% for this year and 306.49% for next year.
Float and Shares Shorts:
At present, 66.72 million AMLX shares are outstanding with a float of 49.98 million shares on hand for trading. On Apr 27, 2023, short shares totaled 6.87 million, which was 10.24% higher than short shares on Mar 30, 2023. In addition to Mr. Joshua B. Cohen as the firm’s Co-Founder, Co-CEO & Director, Mr. Justin B. Klee serves as its Co-Founder, Co-CEO & Director.
Through their ownership of 81.99% of AMLX’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 51.90% of AMLX, in contrast to 23.68% held by mutual funds. Shares owned by individuals account for 20.24%. As the largest shareholder in AMLX with 9.13% of the stake, Perceptive Advisors LLC holds 6,088,333 shares worth 6,088,333. A second-largest stockholder of AMLX, Viking Global Investors LP, holds 4,634,606 shares, controlling over 6.95% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in AMLX, holding 4,307,738 shares or 6.46% stake. With a 2.48% stake in AMLX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 1,653,907 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.08% of AMLX stock, is the second-largest Mutual Fund holder. It holds 1,388,001 shares valued at 39.42 million. iShares Russell 2000 ETF holds 1.60% of the stake in AMLX, owning 1,065,916 shares worth 30.27 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Mar 30, 2023, AMLX reported revenue of $0.00 and operating income of -$54.25M. The EBITDA in the recently reported quarter was -$54.15M and diluted EPS was -$0.93.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AMLX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AMLX analysts setting a high price target of $53.00 and a low target of $45.00, the average target price over the next 12 months is $49.67. Based on these targets, AMLX could surge 93.43% to reach the target high and rise by 64.23% to reach the target low. Reaching the average price target will result in a growth of 81.28% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded AMLX stock several times over the past three months with 15 Buys and 28 Sells. In these transactions, 330,991 shares were bought while 995,715 shares were sold. The number of buy transactions has increased to 26 while that of sell transactions has risen to 43 over the past year. The total number of shares bought during that period was 355,022 while 2,596,790 shares were sold.